ID

12119

Descrizione

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT; ODM derived from: https://clinicaltrials.gov/show/NCT02460887

collegamento

https://clinicaltrials.gov/show/NCT02460887

Keywords

versioni (1)
  1. 24/09/15 24/09/15 - Julian Varghese
Caricato su

24 settembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Nasopharyngeal Carcinoma NCT02460887

Inglese

Eligibility Nasopharyngeal Carcinoma NCT02460887

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with newly histologically confirmed non-keratinizing nasopharyngeal carcinoma (including who ii or iii).
Descrizione

Nasopharyngeal Nonkeratinizing Carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1334926
tumor staged as t1-4n2-3或t3-4n0-1m0 (according to the 7th ajcc edition).
Descrizione

AJCC tumor staging

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0441915
satisfactory performance status: karnofsky scale (kps) ≥ 70.
Descrizione

satisfactory performance status: karnofsky scale

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
adequate marrow: leucocyte count ≥ 4000/μl, hemoglobin ≥ 90g/l and platelet count ≥
Descrizione

platelet count; hemoglobin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0005821
UMLS CUI [3]
C0019046
adequate liver function: alanine aminotransferase (alt), aspartate aminotransferase (ast) < 1.5×upper limit of normal (uln) concomitant with alkaline phosphatase (alp) ≤ 2.5×uln
Descrizione

alkaline phosphatase; concomitant; normal; liver; upper; ast; uln

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0376147
UMLS CUI [2]
C0242192
UMLS CUI [3]
C0201850
and bilirubin ≤1.5×uln.
Descrizione

bilirubin; uln

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1278039
adequate renal function: creatinine clearance ≥ 60 ml/min.
Descrizione

creatinine clearance; renal function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0373595
patients must be informed of the investigational nature of this study and give written informed consent.
Descrizione

written informed consent.; study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
Descrizione

Basaloid squamous cell carcinoma | Squamous cell carcinoma, keratinizing

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1266005
UMLS CUI [2]
C0334247
treatment with palliative intent.
Descrizione

palliative; treatment; intent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1285530
prior malignancy except adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer.
Descrizione

prior malignancy; cervical; squamous; cancer; skin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
pregnancy or lactation (consider pregnancy test in women of child-bearing age and emphasize effective contraception during the treatment period).
Descrizione

Patient currently pregnant | Lactating (finding)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0549206
UMLS CUI [2]
C2828358
history of previous rt (except for non-melanomatous skin cancers outside intended rt treatment volume).
Descrizione

history of previous rt

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1522449
prior chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
Descrizione

prior chemotherapy; primary tumor; surgery; nodes

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2,1]
C0038894
UMLS CUI [2,2]
C0006826
any severe intercurrent disease, which may bring unacceptable risk or affect the compliance of the trial, for example, unstable cardiac disease requiring treatment, renal disease, chronic hepatitis, diabetes with poor control (fasting plasma glucose > 1.5×uln), and emotional disturbance.
Descrizione

Disease condition determination, uncontrolled | Compliance behavior | Heart Diseases; Unstable status | Kidney Diseases | Hepatitis, Chronic | Diabetes mellitus poor control | Emotional Disturbances

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0184774
UMLS CUI [2]
C1321605
UMLS CUI [3,1]
C0018799
UMLS CUI [3,2]
C0443343
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0019189
UMLS CUI [6]
C0860161
UMLS CUI [7]
C0013985
Ritorna all'inizio della pagina

Similar models

Eligibility Nasopharyngeal Carcinoma NCT02460887

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Nasopharyngeal Nonkeratinizing Carcinoma
Item
patients with newly histologically confirmed non-keratinizing nasopharyngeal carcinoma (including who ii or iii).
boolean
C1334926 (UMLS CUI [1])
AJCC tumor staging
Item
tumor staged as t1-4n2-3或t3-4n0-1m0 (according to the 7th ajcc edition).
boolean
C0441915 (UMLS CUI [1])
satisfactory performance status: karnofsky scale
Item
satisfactory performance status: karnofsky scale (kps) ≥ 70.
boolean
C1520224 (UMLS CUI [1])
platelet count; hemoglobin
Item
adequate marrow: leucocyte count ≥ 4000/μl, hemoglobin ≥ 90g/l and platelet count ≥
boolean
C0023508 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
C0019046 (UMLS CUI [3])
alkaline phosphatase; concomitant; normal; liver; upper; ast; uln
Item
adequate liver function: alanine aminotransferase (alt), aspartate aminotransferase (ast) < 1.5×upper limit of normal (uln) concomitant with alkaline phosphatase (alp) ≤ 2.5×uln
boolean
C0376147 (UMLS CUI [1])
C0242192 (UMLS CUI [2])
C0201850 (UMLS CUI [3])
bilirubin; uln
Item
and bilirubin ≤1.5×uln.
boolean
C1278039 (UMLS CUI [1])
creatinine clearance; renal function
Item
adequate renal function: creatinine clearance ≥ 60 ml/min.
boolean
C0373595 (UMLS CUI [1])
written informed consent.; study
Item
patients must be informed of the investigational nature of this study and give written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Basaloid squamous cell carcinoma | Squamous cell carcinoma, keratinizing
Item
who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
boolean
C1266005 (UMLS CUI [1])
C0334247 (UMLS CUI [2])
palliative; treatment; intent
Item
treatment with palliative intent.
boolean
C0087111 (UMLS CUI [1,1])
C1285530 (UMLS CUI [1,2])
prior malignancy; cervical; squamous; cancer; skin
Item
prior malignancy except adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer.
boolean
C0006826 (UMLS CUI [1])
Patient currently pregnant | Lactating (finding)
Item
pregnancy or lactation (consider pregnancy test in women of child-bearing age and emphasize effective contraception during the treatment period).
boolean
C0549206 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
history of previous rt
Item
history of previous rt (except for non-melanomatous skin cancers outside intended rt treatment volume).
boolean
C1522449 (UMLS CUI [1])
prior chemotherapy; primary tumor; surgery; nodes
Item
prior chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
boolean
C0392920 (UMLS CUI [1])
C0038894 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
Disease condition determination, uncontrolled | Compliance behavior | Heart Diseases; Unstable status | Kidney Diseases | Hepatitis, Chronic | Diabetes mellitus poor control | Emotional Disturbances
Item
any severe intercurrent disease, which may bring unacceptable risk or affect the compliance of the trial, for example, unstable cardiac disease requiring treatment, renal disease, chronic hepatitis, diabetes with poor control (fasting plasma glucose > 1.5×uln), and emotional disturbance.
boolean
C0184774 (UMLS CUI [1])
C1321605 (UMLS CUI [2])
C0018799 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C0022658 (UMLS CUI [4])
C0019189 (UMLS CUI [5])
C0860161 (UMLS CUI [6])
C0013985 (UMLS CUI [7])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial